Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. (Q53961036)
Jump to navigation
Jump to search
scientific article published in January 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. |
scientific article published in January 1998 |
Statements
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2 (English)
C F LeMaistre
M N Saleh
T M Kuzel
F Foss
L C Platanias
G Schwartz
A Rook
C O Freytes
F Craig
J Reuben